Drug Discovery Research Area
Drug Discovery
SCREEN-WELL compound libraries, HTS-ready assay platforms, and ADME/Tox tools to accelerate your pipeline from target to lead.
Accelerating the Path from Target to Therapy
Drug discovery demands reliable tools at every stage — from target identification through lead optimization. Enzo Life Sciences supports pharmaceutical, biotech, and academic screening programs with our proprietary SCREEN-WELL compound libraries, miniaturized assay platforms, and predictive ADME/Tox kits. Our products are trusted by leading institutions worldwide for their quality, reproducibility, and broad target coverage.
SCREEN-WELL Compound Libraries
Pre-plated, annotated compound collections for efficient screening. Choose from FDA-approved drug libraries, natural product collections, kinase inhibitor panels, and pathway-focused sets. Each library includes detailed annotations with target, pathway, and reference data.
High-Throughput Screening Assays
Miniaturized, plate-reader compatible assay kits optimized for 96- and 384-well formats. Our FLUOR DE LYS platform enables sensitive detection of HDAC and Sirtuin activity, while SENTINEL assays monitor cellular stress responses in real time.
ADME/Tox Screening
Evaluate drug safety early with in vitro assays for cytochrome P450 activity, mitochondrial toxicity, cytotoxicity, and genotoxicity. Our predictive screening tools help identify problematic compounds before costly in vivo studies.
Target Validation Reagents
Validate your drug targets with our extensive catalog of selective enzyme inhibitors, receptor ligands, and bioactive small molecules. Each compound is quality-tested with detailed bioactivity data and supported by peer-reviewed literature.